April 12, 2025
We are proud to announce that our U.S. patent US 12,268,712B2 has officially been granted. This milestone recognizes our innovation and dedication... Read More
March 20, 2025
Our abstract entitled “Improving Vaginal Health With a Zinc-Containing Vaginal Hydrogel: A Prospective Cohort Study” has been selected as a Moderated E-Poster/Scientific... Read More
March 19, 2025
In a paper, published in Gels (an MDPI journal), we have showed JUVIAGEL’s role as an effective, nonhormonal, drug-free, and local adjunct... Read More
December 7, 2023
In a paper, published in Science Translational Medicine, we have showed that JUVIAGEL could be effective against recurrent yeast infections. More in... Read More
July 17, 2023
Fempharma has been successfully audited for ISO 13485:2016 Manufacturing and Trade of Medical Devices by Tequa-Zert, a TÜV Hessen partner.
June 25th, 2023
We have presented our latest study “A randomized controlled pilot trial to assess the effectiveness of a specially formulated food supplement and... Read More
June 22, 2023
Our latest study about the efficacy of INCOXIL has been published at the BMC Women’s Health titled “A randomized controlled pilot trial... Read More
May 21st, 2023
We have presented our latest study “A randomized controlled trial to assess the effectiveness of a specially formulated food supplement and pelvic... Read More
May 19th, 2023
New clinical trial for Juvia has started. Vaginitis is one of the most common gynecological problems in women. Candida albicans is responsible... Read More